Newera
Blog/Tutorials
TUTORIALSNov 4, 2026 · 1 min read

UBS Maintains Buy on Amgen, Raises Price Target to $530

By Benzinga Newsdesk

UBS analyst Michael Yee maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $470 to $530.

Share this article

Keep reading.

TUTORIALS

UBS Maintains Buy on Amgen, Raises Price Target to $530

TUTORIALS

Scotiabank Maintains Sector Outperform on Amgen, Raises Price Target to $530

TUTORIALS

'Goldman, Apollo in Talks to Sell SpaceX’s $40 Billion AI Deal' - Bloomberg Exclusive

Trade what
you just read.

Apply the analysis on a live or demo account, same execution, no risk on demo.

Your seat at the market is ready.

Open your account in minutes, transparent pricing, fast withdrawals and support that answers.

Try a free demo

CFDs are complex instruments. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.